Promising assessments of intracellular delivery performance in different cell-types suggest the potential for developing MGMR® as a biomolecular delivery vehicle for diverse cell-types and expression platforms of interest to therapeutic, biomanufacturing, agricultural and industrial applications.
Robust cellular uptake observed with MGMR offers the potential to deliver molecular payloads to difficult-to-penetrate cell-types or those acutely sensitive to detergents and other conventional methods for transmembrane delivery.
In a murine therapeutic model, MGMR loaded with doxorubicin (Dox) demonstrated a remarkable capability to rapidly concentrate drug in targeted tissues and extend half-life of its molecular cargo.
Excellent cytotoxicity profile
Biopact has evaluated the cytotoxicity profile of MGMR across multiple cell-lines and investigated safety and efficacy in murine biodistribution and clearance models. Our in vivo studies demonstrate that MGMR is biologically-inert, well-tolerated and rapidly cleared from non-targeted tissues.
Work with us
Biopact offers a simple process to test MGMR’s delivery capability with your payload
Intracellular delivery of your biomolecule is within reach
Upload the biomolecule
of your choice
Transport it to your desired
intracellular location
